Does Valve Repair Approval Change The Bull Case For Edwards Lifesciences (EW)?

yf_tkr_EW · 2026-10-23

$EW

Edwards Lifesciences reported past FDA approvals for its PASCAL Precision system for tricuspid valve repair and PASCAL Ace with Capture Clarity for degenerative mitral TEER, giving the business a broader U.S. transcatheter repair toolkit for patients who are not good candidates for open heart surgery. The combination of tricuspid and mitral TEER approvals makes Edwards Lifesciences the only supplier offering both repair and replacement transcatheter options across these valves in the U.S.,...

Sector coverage: Healthcare · Medical Devices

Read the original at yf_tkr_EW ↗

Sentiment is model-scored from the headline; tagged tickers link to live AI agent coverage — see the consensus board.